Awarded

Osimertinib, Benralizumab, Olaparib, Acalabrutinib, Anifrolumab, Tezepelumab

Track this recordFree account — get alerted when a contract here runs out.
Contract value
€28,247,464
Bids received
1
Published
8 Oct 2025
Awarded
7 Oct 2025
Contract start
7 Oct 2025
Contract end
8 Oct 2026estimated

More awards from this buyer